 Cortexyme, Inc. Nasdaq: CRTX, a clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to treat what it believes to be a key underlying cause of Alzheimers and other degenerative diseases, today announced Casey Lynch, the companys chief executive officer, chair, and co-founder, will participate in a fireside chat at the virtual BofA Securities 2020 Health Care Conference on Wednesday, May 13, 2020 at 1:00 p.m. EDT 10:00 a.m. PDT. 